Trade

with

Zimmer Holdings Inc
(NYSE: ZMH)
AdChoices
105.29
+0.72
+0.69%
After Hours :
107.93
+2.64
+2.51%

Open

104.57

Previous Close

104.57

Volume (Avg)

573.88k (1.26M)

Day's Range

104.55-105.50

52Wk Range

85.04-108.33

Market Cap.

17.79B

Dividend Rate (Yield )

0.88 (0.82%)

Beta

0.94

Shares Outstanding

168.92M

P/E Ratio (EPS)

22.99 (4.58)

AdChoices
Fundamentals
  • Key statistics
  • Growth
  • Profitability
  • Financial health
  • Price ratios
  • Trading statistics
Industry Medical Devices
Highlights
Analyst Recommendation: Buy
    • Revenue

    • 4.62B

    • Net Income

    • 761.00M

    • Market Cap.

    • 17.79B

    • Enterprise Value

    • -

    • Net Profit Margin %

    • 16.92

    • PEG (Price/Earnings Growth) Ratio

    • 1.71

    • Beta

    • 0.94

    • Forward P/E

    • 16.37

    • Price/Sales

    • 3.89

    • Price/Book Value

    • 2.76

    • Price/Cash flow

    • 16.47

      • EBITDA

      • 1.41B

      • Return on Capital %

      • 8.42

      • Return on Equity %

      • 12.78

      • Return on Assets %

      • 8.42

      • Book Value/Share

      • 38.19

      • Shares Outstanding

      • 168.92M

      • Last Split Factor (Date)

      • -

      • Last Dividend (Ex-Date)

      • 0.22 (9/24/2014)

      • Dividend Declaration Date

      • 8/26/2014

      Analyst Recommendation
      10/21/2014
      Buy
        • 1 Year Price Target

        • 119.29

        • Credit Rating

        • BBB+

        • Analysts

        • 10

        • EPS Estimate

        • 5.72

        • Cashflow Estimate

        • 7.60

        Morningstar Consensus estimate data
        • Growth Rate (%)

        • Company

        • Industry

          • Sales (Revenue)

            Q/Q (last year)

          • 1.10

          • 2.66

          • Net Income

            YTD/YTD (last year)

          • 0.80

          • -22.64

          • Net Income

            Q/Q (last year)

          • 16.00

          • -29.83

          • Sales (Revenue)

            5-Year Annual Average

          • 2.33

          • 4.60

          • Net Income

            5-Year Annual Average

          • -2.20

          • -1.34

          • Dividends

            5-Year Annual Average

          • -

          • -0.25

          • Profit Margins (%)

          • Company

          • Industry

            • Gross Margin

            • 71.92

            • 64.08

            • Pre-Tax Margin

            • 21.97

            • 15.19

            • Net Profit Margin

            • 16.92

            • 13.09

            • Average Gross Margin

              5-Year Annual Average

            • 74.70

            • 65.03

            • Average Pre-Tax Margin

              5-Year Annual Average

            • 22.00

            • 17.99

            • Average Net Profit Margin

              5-Year Annual Average

            • 16.40

            • 191.75B

            • Financial Ratios

            • Company

            • Industry

              • Debt/Equity Ratio

              • 0.26

              • 0.34

              • Current Ratio

              • 4.44

              • 2.55

              • Quick Ratio

              • 2.78

              • 1.83

              • Interest Coverage

              • 16.90

              • 11.70

              • Leverage Ratio

              • 1.49

              • 1.86

              • Book Value/Share

              • 38.19

              • 11.67

              • Price Ratios

              • Company

              • Industry

                • Current P/E Ratio

                • 21.65

                • 35.09

                • P/E Ratio 5-Year High

                • 23.66

                • 224.03

                • P/E Ratio 5-Year Low

                • 10.10

                • 60.23

                • Price/Sales Ratio

                • 3.66

                • 3.24

                • Price/Book Value

                • 2.60

                • 3.29

                • Price/Cash Flow Ratio

                • 16.47

                • 19.05

                • Key Metrics

                • Company

                • Industry

                  • Return on Equity %

                    (5-Year Average)

                  • 12.78

                    (12.50)

                  • 12.33

                    (18.16)

                  • Return on Assets %

                    (5-Year Average)

                  • 8.42

                    (8.60)

                  • 6.62

                    (8.69)

                  • Return on Capital %

                    (5-Year Average)

                  • 10.66

                    (10.50)

                  • 8.49

                    (11.48)

                  • Income/Employee

                  • 82.98k

                  • 34.11k

                  • Inventory Turnover

                  • 1.19

                  • 2.77

                  • Asset Turnover

                  • 0.50

                  • 0.51

                  Current Historical
                  Financials
                  • Income Statement
                  • Balance Sheet
                  • Cash Flow
                  Operating Income
                  1.04B
                  Operating Margin
                  22.40
                  Total Equity
                  -
                  Retained Earnings
                  -
                  Free Cashflow
                  -
                  Price/Cashflow
                  16.47
                  Company Profile

                  Sector

                  Healthcare

                  Industry

                  Medical Devices

                  Type

                  Slow Growth

                  Style

                  Large Growth

                  Zimmer Holdings, Inc., was incorporated in 2001. The Company designs, develops, manufactures and markets orthopaedic reconstructive, spinal and trauma devices, biologics, dental implants and related surgical products. It also provide...mores other healthcare related services. Its products include orthopaedic reconstructive implants, spinal and trauma devices, biologics, dental implants and related surgical products. Its orthopaedic reconstructive devices restore function lost due to disease or trauma in joints such as knees, hips, shoulders and elbows. Its dental reconstructive implants restore function and aesthetics in patients who have lost teeth due to trauma or disease. Its spinal devices are utilized by orthopaedic surgeons and neurosurgeons in the treatment of degenerative diseases, deformities and ...moretrauma in all regions of the spine. Its trauma products are devices used to reattach or stabilize damaged bone and tissue to support the body's natural healing process. The Company has its operations in more than 25 countries and markets its products in more than 100 countries. The Company operates in a single industry but have three reportable geographic segments, the Americas, Europe and Asia Pacific. The Americas, which is comprised of the U.S. and includes other North, Central and South American markets; Europe, which is comprised of Europe and includes the Middle East and African markets; and Asia Pacific, which is comprised of Japan and includes other Asian and Pacific markets. The Company's customers include orthopaedic surgeons, neurosurgeons, oral surgeons, dentists, hospitals, stocking distributors, healthcare dealers and, in their capacity as agents, healthcare purchasing organizations or buying groups. It markets and sells its products through three channels; direct to healthcare institutions, such as hospitals, referred to as direct channel accounts; through stocking distributors and healthcare dealers; and directly to dental practices and dental laboratories. The Company operates distribution facilities domestically in Warsaw, Indiana; Southaven, Mississippi; and Carlsbad, California and internationally in Australia, Austria, Belgium, Canada, the Czech Republic, China, Finland, France, Germany, Hong Kong, India, Italy, Japan, Korea, Malaysia, the Netherlands, New Zealand, Portugal, Russia, Singapore, South Africa, Spain, Sweden, Switzerland, Taiwan, Thailand and the United Kingdom. The Company competes with the DePuy Synthes Companies of Johnson & Johnson, Stryker Corporation, Biomet, Inc., and Smith & Nephew plc. It protects its proprietary rights through a variety of methods, including confidentiality agreements and proprietary information agreements with vendors, employees, consultants and others who may have access to proprietary information. The Company is subject to government regulation in the countries in which it conducts business.lessless

                  Key People

                  David C. Dvorak

                  CEO/President/Director

                  James T. Crines

                  CFO/Executive VP, Divisional

                  Derek M. Davis

                  Chief Accounting Officer/Controller/Vice President, Divisional

                  Arthur J. Higgins

                  Director

                  Betsy J. Bernard

                  Director

                  • Zimmer Holdings Inc

                  • 345 East Main Street

                  • Warsaw, IN 46580

                  • USA.Map

                  • Phone: +1 574 267-6131

                  • Fax: -

                  • zimmer.com

                  Incorporated

                  2001

                  Employees

                  9,500